{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:25:46Z","timestamp":1785464746611,"version":"3.56.0"},"reference-count":34,"publisher":"e-Century Publishing Corporation","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/zbev1016","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T08:57:12Z","timestamp":1761728232000},"page":"7557-7568","source":"Crossref","is-referenced-by-count":1,"title":["Effects of montelukast on allergic rhinitis in children: a systematic review and meta-analysis"],"prefix":"10.62347","volume":"17","author":[{"given":"Qing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.iac.2021.07.010","article-title":"Allergic rhinitis in children and adolescents","volume":"41","author":"Schuler Iv","year":"2021","unstructured":"Schuler Iv CF and Montejo JM. Allergic rhinitis in children and adolescents. Immunol Allergy Clin North Am 2021; 41: 613-625.","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/all.12235","article-title":"Paediatric rhinitis: position paper of the European academy of allergy and clinical immunology","volume":"68","author":"Roberts","year":"2013","unstructured":"Roberts G, Xatzipsalti M, Borrego LM, Custovic A, Halken S, Hellings PW, Papadopoulos NG, Rotiroti G, Scadding G, Timmermans F and Valovirta E. Paediatric rhinitis: position paper of the European academy of allergy and clinical immunology. Allergy 2013; 68: 1102-1116.","journal-title":"Allergy"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1452410","DOI":"10.3389\/fimmu.2024.1452410","article-title":"New progress in pediatric allergic rhinitis","volume":"15","author":"Cheng","year":"2024","unstructured":"Cheng M, Dai Q, Liu Z, Wang Y and Zhou C. New progress in pediatric allergic rhinitis. Front Immunol 2024; 15: 1452410.","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.5152\/TurkArchPediatr.2022.21269","article-title":"The asthma risk is increased in children with severe allergic rhinitis","volume":"57","author":"Akca &#xDC","year":"2022","unstructured":"Kaya Akca Ü, Maslak İC, Uygun D and Bingöl A. The asthma risk is increased in children with severe allergic rhinitis. Turk Arch Pediatr 2022; 57: 391-397.","journal-title":"Turk Arch Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.12998\/wjcc.v11.i28.6725","article-title":"Efficacy and anti-inflammatory analysis of glucocorticoid, antihistamine and leukotriene receptor antagonist in the treatment of allergic rhinitis","volume":"11","author":"Qiu","year":"2023","unstructured":"Qiu C and Feng D. Efficacy and anti-inflammatory analysis of glucocorticoid, antihistamine and leukotriene receptor antagonist in the treatment of allergic rhinitis. World J Clin Cases 2023; 11: 6725-6732.","journal-title":"World J Clin Cases"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"174196","DOI":"10.1016\/j.ejphar.2021.174196","article-title":"Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity","volume":"904","author":"Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Almulaiky YQ, Cruz-Martins N and El-Saber Batiha G. Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity. Eur J Pharmacol 2021; 904: 174196.","journal-title":"Eur J Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/088318704322994958","article-title":"A comparison of cetirizine and montelukast for treating childhood perennial allergic rhinitis","volume":"17","author":"Hsieh","year":"2004","unstructured":"Hsieh JC, Lue KH, Lai DS, Sun HL and Lin YH. A comparison of cetirizine and montelukast for treating childhood perennial allergic rhinitis. Pediatric Asthma, Allergy & Immunology 2004; 17: 59-69.","journal-title":"Pediatric Asthma Allergy &#x0026 Immunology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1399-3038.2005.00351.x","article-title":"Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr","volume":"17","author":"Chen","year":"2006","unstructured":"Chen ST, Lu KH, Sun HL, Chang WT, Lue KH and Chou MC. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. Pediatr Allergy Immunol 2006; 17: 49-54.","journal-title":"Pediatr Allergy Immunol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1081-1206(10)60968-4","article-title":"Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis","volume":"97","author":"Razi","year":"2006","unstructured":"Razi C, Bakirtas A, Harmanci K, Turktas I and Erbas D. Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2006; 97: 767-74.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1442-200X.2007.02375.x","article-title":"Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis","volume":"49","author":"Hung","year":"2007","unstructured":"Hung CH, Hua YM, Hsu WT, Lai YS, Yang KD, Jong YJ and Chu YT. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis. Pediatr Int 2007; 49: 322-7.","journal-title":"Pediatr Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/ppul.21102","article-title":"Leukotriene receptor antagonist in the treatment of childhood allergic rhinitis-a randomized placebo-controlled study","volume":"44","author":"AM","year":"2009","unstructured":"Li AM, Abdullah VJ, Tsen CS, Au CT, Lam HS, So HK, Chan MH, Leung AW, Chan IH, Lam CW and Ng PC. Leukotriene receptor antagonist in the treatment of childhood allergic rhinitis-a randomized placebo-controlled study. Pediatr Pulmonol 2009; 44: 1085-1092.","journal-title":"Pediatr Pulmonol"},{"key":"ref11","unstructured":"Mahajan R, Gupta AK, Gupta K, Bansal A and Kapoor V. Efficacy and tolerability of montelukast and levocetirizine in seasonal allergic rhinitis in children aged 2-5 years: a comparative study. J Res Med Educ Ethics 2012; 2: 248-253."},{"key":"ref12","unstructured":"Yang ZH and Peng XY. Clinical effect of YupingfengGranules on children with allergic rhinitis. Pharmaceutical Journal of Chinese People’s Liberation Army 2018; 34: 266-267, 280."},{"key":"ref13","unstructured":"Wu B, Zhuang X, Ai S and Zheng J. Clinical efficacy of ketotifen tablets and montelukast sodium tablets as a combination treatment for children with allergic rhinitis and their effect on serum inflammatory factors. Int J Clin Exp Med 2020; 13: 758-765."},{"key":"ref14","unstructured":"Dai W, Zhen N, Qin X and Cao J. Effect of momethasone furoate combined with loratadine and montelukast sodium on inflammatory factors and pulmonary function in children with allergic rhinitis. Am J Transl Res 2022; 14: 7199-7207."},{"key":"ref15","unstructured":"Guo S and Cao C. Effects of montelukast sodium combined with budesonide on pulmonary function, serum IgE levels, and EOS percentage in children with comorbid allergic rhinitis and asthma. Am J Transl Res 2023; 15: 6823-6831."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.12669\/pjms.39.5.6985","article-title":"Efficacy of Montelukast combined with Sublingual Immunotherapy in the treatment of children with Obstructive Sleep Apnea Hypopnea Syndrome Complicated with allergic rhinitis","volume":"39","author":"Mao","year":"2023","unstructured":"Mao X and Zhao W. Efficacy of Montelukast combined with Sublingual Immunotherapy in the treatment of children with Obstructive Sleep Apnea Hypopnea Syndrome Complicated with allergic rhinitis. Pak J Med Sci 2023; 39: 1350-1354.","journal-title":"Pak J Med Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.18502\/ijaai.v23i4.16211","article-title":"Comparative efficacy of mometasone nasal spray combined with different doses of desloratadine, and montelukast in childhood allergic rhinitis: a randomized clinical trial","volume":"23","author":"Ghanbari","year":"2024","unstructured":"Ghanbari N, Eftekhari K, Samadzadeh-Mamaghani M, Sedighiyan M, Diaz DN and Shafiei A. Comparative efficacy of mometasone nasal spray combined with different doses of desloratadine, and montelukast in childhood allergic rhinitis: a randomized clinical trial. Iran J Allergy Asthma Immunol 2024; 23: 366-373.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.62347\/HYBG4442","article-title":"Montelukast sodium combined with levocabastine nasal spray demonstrates high efficacy in treating pediatric allergic rhinitis","volume":"17","author":"Yang","year":"2025","unstructured":"Yang J, Wang Y, Li L, Xiong J and Mao D. Montelukast sodium combined with levocabastine nasal spray demonstrates high efficacy in treating pediatric allergic rhinitis. Am J Transl Res 2025; 17: 3142-3151.","journal-title":"Am J Transl Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.18502\/ijaai.v24i3.18677","article-title":"Effect of Montelukast and budesonide aerosol inhalation in the treatment of allergic rhinitis and asthma in children and its effect on the inflammatory response of children","volume":"24","author":"Li","year":"2025","unstructured":"Li H, Nie L, Zhang T, Chen Z and Gao S. Effect of Montelukast and budesonide aerosol inhalation in the treatment of allergic rhinitis and asthma in children and its effect on the inflammatory response of children. Iran J Allergy Asthma Immunol 2025; 24: 268-276.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3390\/genes12122004","article-title":"Genetics and epigenetics in allergic rhinitis","volume":"12","author":"Choi","year":"2021","unstructured":"Choi BY, Han M, Kwak JW and Kim TH. Genetics and epigenetics in allergic rhinitis. Genes (Basel) 2021; 12: 2004.","journal-title":"Genes (Basel)"},{"key":"ref21","unstructured":"He Y, Chen Y, Xu S, Luo Y, Qin F and Hu W. Pathogenesis and key cells in allergic rhinitis. Int Arch Allergy Immunol 2025; 186: 418-429."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41572-020-00227-0","article-title":"Allergic rhinitis","volume":"6","author":"Bousquet","year":"2020","unstructured":"Bousquet J, Anto JM, Bachert C, Baiardini I, Bosnic-Anticevich S, Walter Canonica G, Melén E, Palomares O, Scadding GK, Togias A and Toppila-Salmi S. Allergic rhinitis. Nat Rev Dis Primers 2020; 6: 95.","journal-title":"Nat Rev Dis Primers"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1146\/annurev-pathmechdis-111523-023509","article-title":"Cysteinyl leukotrienes in allergic inflammation","volume":"20","author":"Lee","year":"2025","unstructured":"Lee M, Boyce JA and Barrett NA. Cysteinyl leukotrienes in allergic inflammation. Annu Rev Pathol 2025; 20: 115-141.","journal-title":"Annu Rev Pathol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"118452","DOI":"10.1016\/j.lfs.2020.118452","article-title":"Leukotriene D4 role in allergic asthma pathogenesis from cellular and therapeutic perspectives","volume":"260","author":"Al-Azzam","year":"2020","unstructured":"Al-Azzam N and Elsalem L. Leukotriene D4 role in allergic asthma pathogenesis from cellular and therapeutic perspectives. Life Sci 2020; 260: 118452.","journal-title":"Life Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1081-1206(10)61317-8","article-title":"The role of leukotrienes in allergic rhinitis","volume":"94","author":"Peters-Golden","year":"2005","unstructured":"Peters-Golden M and Henderson WR Jr. The role of leukotrienes in allergic rhinitis. Ann Allergy Asthma Immunol 2005; 94: 609-618.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/all.13228","article-title":"Is the atopic march related to confounding by genetics and early-life environment? A systematic review of sibship and twin data","volume":"73","author":"Khan","year":"2018","unstructured":"Khan SJ, Dharmage SC, Matheson MC and Gurrin LC. Is the atopic march related to confounding by genetics and early-life environment? A systematic review of sibship and twin data. Allergy 2018; 73: 17-28.","journal-title":"Allergy"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/ph15091039","article-title":"Montelukast-activity, metabolism, and toxicity hints for repurposing","volume":"15","author":"CF","year":"2022","unstructured":"Marques CF, Marques MM and Justino GC. Leukotrienes vs. Montelukast-activity, metabolism, and toxicity hints for repurposing. Pharmaceuticals (Basel) 2022; 15: 1039.","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1080\/02770903.2024.2370002","article-title":"Montelukast treatment response according to eosinophil-derived neurotoxin level in children with allergic rhinitis","volume":"61","author":"Lee","year":"2024","unstructured":"Lee YJ, Ma HS, Callaway Z and Kim CK. Montelukast treatment response according to eosinophil-derived neurotoxin level in children with allergic rhinitis. J Asthma 2024; 61: 1611-1618.","journal-title":"J Asthma"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Chen H, Zhang L, Lou H, Wang Y, Cao F and Wang C. A randomized trial of comparing a combination of Montelukast and budesonide with budesonide in allergic rhinitis. Laryngoscope 2021; 131: E1054-E1061.","DOI":"10.1002\/lary.28433"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.biopha.2016.08.003","article-title":"The efficacy and safety of H1-antihistamine versus Montelukast for allergic rhinitis: a systematic review and meta-analysis","volume":"83","author":"Wei","year":"2016","unstructured":"Wei C. The efficacy and safety of H1-antihistamine versus Montelukast for allergic rhinitis: a systematic review and meta-analysis. Biomed Pharmacother 2016; 83: 989-997.","journal-title":"Biomed Pharmacother"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"230124","DOI":"10.1183\/16000617.0124-2023","article-title":"Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis","volume":"32","author":"Mayoral","year":"2023","unstructured":"Mayoral K, Lizano-Barrantes C, Zamora V, Pont A, Miret C, Barrufet C, Caballero-Rabasco MA, Praena-Crespo M, Bercedo A, Valdesoiro-Navarrete L, Guerra MT, Pardo Y, Martínez Zapata MJ, Garin O and Ferrer M; ARCA Group. Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis. Eur Respir Rev 2023; 32: 230124.","journal-title":"Eur Respir Rev"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.alit.2019.06.002","article-title":"Cysteinyl leukotriene metabolism of human eosinophils in allergic disease","volume":"69","author":"Miyata","year":"2020","unstructured":"Miyata J, Fukunaga K, Kawashima Y, Ohara O and Arita M. Cysteinyl leukotriene metabolism of human eosinophils in allergic disease. Allergol Int 2020; 69: 28-34.","journal-title":"Allergol Int"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00011-024-01974-6","article-title":"Histamine and TH2 cytokines regulate the biosynthesis of cysteinyl-leukotrienes and expression of their receptors in human mast cells","volume":"74","author":"Gehlhaar","year":"2025","unstructured":"Gehlhaar P, Schaper-Gerhardt K, Gutzmer R, Hasler F, Röhn TA, Werfel T and Mommert S. Histamine and TH2 cytokines regulate the biosynthesis of cysteinyl-leukotrienes and expression of their receptors in human mast cells. Inflamm Res 2025; 74: 32.","journal-title":"Inflamm Res"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/10\/ajtr0167647.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:38:40Z","timestamp":1769063920000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/10\/ajtr0167647.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/zbev1016","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}